Filter
308
Text search:
pharmaceutical
procurement
Featured
Recommendations
33
New Publications
83
Language
Document type
No document type
147
Studies & Reports
64
Guidelines
48
Strategic & Response Plan
25
Manuals
11
Fact sheets
5
Training Material
3
Situation Updates
3
Resource Platforms
2
Countries / Regions
Ethiopia
20
Kenya
20
India
9
Rwanda
9
South Africa
9
Malawi
9
Global
8
Sierra Leone
7
Ghana
7
Western and Central Europe
7
Uganda
6
Nepal
6
Zambia
6
Liberia
5
Nigeria
5
Senegal
5
Zimbabwe
5
Philippines
5
Africa
5
Eastern Europe
5
Tanzania
4
Namibia
4
Ukraine
4
Syria
3
Bangladesh
3
Congo, Democratic Republic of
2
Cambodia
2
Sudan
2
Benin
2
Latin America and the Carribbean
2
Burkina Faso
1
Cameroon
1
South Sudan
1
Jordan
1
Indonesia
1
Mozambique
1
Papua New Guinea
1
Eswatini/ Swaziland
1
Brazil
1
North Macedonia
1
Botswana
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Asia
1
Timor Leste/ East Timor
1
Gabon
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
162
Key Resources
19
Clinical Guidelines
17
Public Health
11
Pharmacy & Technologies
9
Women & Child Health
6
Capacity Building
2
Toolboxes
Pharmacy
38
AMR
29
COVID-19
24
TB
20
HIV
19
Conflict
6
Rapid Response
6
NCDs
6
Global Health Education
5
Health Financing Toolbox
5
Caregiver
4
NTDs
4
Ebola & Marburg
3
Planetary Health
3
Natural Hazards
2
Malaria
2
Disability
1
Cholera
1
Polio
1
Refugee
1
Zika
1
Mental Health
1
2.0 Rapid Response
1
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti
...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a
...
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But
...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
14–22 April 2015
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul
...
Final report 2016
This new plan has been developed to build on successes made and lessons learnt from implementation of the two initial plans and to provide a short to medium term strategic anchor against which preparedness and response plans to the corona virus disease COVID-19 epidemic in the country should focus o
...
As a lower-middle-income country (LMIC), South Africa (SA) bears
the burden of maternal and neonatal mortality similar to other sub-
Saharan African countries. According to the Saving Mothers Report
2017/19, there has been a progressive and sustained reduction
in institutional maternal mortality
...
Globally, approximately 56.8 million people are in need of palliative care
services; 78% of them living in low and middle-income country yet only
about 12% have their needs being met causing great suffering for many.
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo
...
These guidelines have been developed for scientific purpose with the main aim to guide the regulatory authority for evaluating probiotic products in our country.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
